MEDTRONIC PUERTO RICO OPERATIONS CO. 640G INSULIN PUMP MMT-1712K; PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR
|
Back to Search Results |
|
Model Number MMT-1712K |
Device Problems
Break (1069); Insufficient Information (3190)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/01/2022 |
Event Type
malfunction
|
Event Description
|
Information received by medtronic indicated that the back side of the insulin pump clip was not working and had alarm during delivery.Customer stated that insulin pump did not rattle when they shaked it.Customer stated that insulin pump was passed in self test and displacement test.No harm requiring medical intervention was reported.Troubleshooting was successfully performed; however, the customer will discontinue use of the device.
|
|
Manufacturer Narrative
|
(b)(4).Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.The insulin pump involved in this event is the ngp 640 insulin pump which is not marketed in the united states.However, the device is similar to the ngp insulin pump, which is marketed in the united states.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Manufacturer Narrative
|
A complete analysis and testing of the insulin pump showed that, unit passed displacement test, rewind test, prime/seating test, basic occlusion test, force sensor test and occlusion test.Unit was monitored and functioning properly.No delivery alarm during testing.The pump history file/traces download was successful using thus.However, unit received with pump error 63 alarm during selftest due to the keypad overlay was removed to perform visual inspection and found a broken trace on u1 keypad assembly.(b)(6) 2022 15:05:53.000 hardware error alarm (63).File =37, line =367 - variable = 3 - ambient light test failure suspecting the hw.Pump was cut open to perform visual inspection and found no evidence of physical or moisture damage on the pcba1, pcba2, force sensor, motor and vibrator assembly noted.Test p-cap and reservoir locked properly into reservoir compartment during testing.The following were noted during visual inspection: cracked select button keypad overlay.Pump error 63 alarm was confirmed.Pump error 63 alarm due to broken trace on u1 keypad assembly.Not confirmed missing segment and no delivery alarm.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|